Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Elfatih Elzein & Jeff Zablocki. (2008) A1 adenosine receptor agonists and their potential therapeutic applications. Expert Opinion on Investigational Drugs 17:12, pages 1901-1910.
Read now
Read now
Luo Yan, Joachim C Burbiel, Astrid Maaß & Christa E Müller. (2003) Adenosine receptor agonists: from basic medicinal chemistry to clinical development. Expert Opinion on Emerging Drugs 8:2, pages 537-576.
Read now
Read now
Articles from other publishers (21)
Karson S. Putt, Yuhong Du, Haian Fu & Zhong-Yin Zhang. (2022) High-throughput screening strategies for space-based radiation countermeasure discovery. Life Sciences in Space Research 35, pages 88-104.
Crossref
Crossref
Pran Kishore Deb, Satyendra Deka, Pobitra Borah, Sara N. Abed & Karl-Norbert Klotz. (2019) Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives. Current Pharmaceutical Design 25:25, pages 2697-2715.
Crossref
Crossref
Stefania Baraldi, Pier Giovanni Baraldi, Paola Oliva, Kiran S. Toti, Antonella Ciancetta & Kenneth A. Jacobson. 2018. The Adenosine Receptors. The Adenosine Receptors
91
136
.
M. HOFER, M. POSPÍŠIL, L. DUŠEK & D. KOMŮRKOVÁ. (2015) Hematopoiesis in 5-Fluorouracil-Treated Adenosine A3 Receptor Knock-Out Mice. Physiological Research, pages 255-262.
Crossref
Crossref
Michal Hofer, Milan Pospíšil, Ladislav Dušek, Zuzana Hoferová & Denisa Komůrková. (2014) Lack of adenosine A3 receptors causes defects in mouse peripheral blood parameters. Purinergic Signalling 10:3, pages 509-514.
Crossref
Crossref
Kazuki Endo, Kazuki Deguchi, Hirokazu Matsunaga, Kota Tomaya & Kohei Yamada. (2014) 8-Substituted 2-alkynyl-N9-propargyladenines as A2A adenosine receptor antagonists. Bioorganic & Medicinal Chemistry 22:12, pages 3072-3082.
Crossref
Crossref
Michal Hofer, Milan Pospíšil, Zuzana Hoferová, Denisa Komůrková, Petr Páral, Filipp Savvulidi & Luděk Šefc. (2012) The pharmacological activation of adenosine A1 and A3 receptors does not modulate the long- or short-term repopulating ability of hematopoietic stem and multipotent progenitor cells in mice. Purinergic Signalling 9:2, pages 207-214.
Crossref
Crossref
M. HOFER, L. DUŠEK, Z. HOFEROVÁ, L. STIXOVÁ & M. POSPÍŠIL. (2011) Expression of mRNA for Adenosine A1, A2a, A2b, and A3 Receptors in HL-60 Cells: Dependence on Cell Cycle Phases. Physiological Research, pages 913-920.
Crossref
Crossref
Michal Hofer, Milan Pospíšil, Ladislav Dušek, Zuzana Hoferová & Lenka Weiterová. (2011) Inhibition of cyclooxygenase-2 promotes the stimulatory action of adenosine A3 receptor agonist on hematopoiesis in sublethally γ-irradiated mice. Biomedicine & Pharmacotherapy 65:6, pages 427-431.
Crossref
Crossref
Michal Hofer, Milan Pospisil, Lenka Weiterova & Zuzana Hoferova. (2011) The Role of Adenosine Receptor Agonists in Regulation of Hematopoiesis. Molecules 16:1, pages 675-685.
Crossref
Crossref
Rosaria Volpini, Diego Dal Ben, Catia Lambertucci, Gabriella Marucci, Ram Chandra Mishra, Anna Teresa Ramadori, Karl-Norbert Klotz, Maria Letizia Trincavelli, Claudia Martini & Gloria Cristalli. (2009)
Adenosine A
2A
Receptor Antagonists: New 8-Substituted 9-Ethyladenines as Tools for in vivo Rat Models of Parkinson's Disease
. ChemMedChem 4:6, pages 1010-1019.
Crossref
Crossref
Pier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Francesca Fruttarolo, Romeo Romagnoli & Delia Preti. (2009) Recent improvements in the development of A2B adenosine receptor agonists. Purinergic Signalling 5:1, pages 3-19.
Crossref
Crossref
Pier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Francesca Fruttarolo, Romeo Romagnoli & Delia Preti. (2008) Recent improvements in the development of A2B adenosine receptor agonists. Purinergic Signalling 4:4, pages 287-303.
Crossref
Crossref
Shane M. Devine & Peter J. Scammells. (2008) An efficient convergent synthesis of adenosine-5′-N-alkyluronamides. Tetrahedron 64:8, pages 1772-1777.
Crossref
Crossref
Catia Lambertucci, Gloria Cristalli, Diego Dal Ben, Dhuldeo D. Kachare, Chiara Bolcato, Karl-Norbert Klotz, Giampiero Spalluto & Rosaria Volpini. (2007) New 2,6,9-trisubstituted adenines as adenosine receptor antagonists: a preliminary SAR profile. Purinergic Signalling 3:4, pages 339-346.
Crossref
Crossref
Pier Giovanni Baraldi, Delia Preti, Mojgan Aghazadeh Tabrizi, Francesca Fruttarolo, Giulia Saponaro, Stefania Baraldi, Romeo Romagnoli, Allan R. Moorman, Stefania Gessi, Katia Varani & Pier Andrea Borea. (2007) N6-[(Hetero)aryl/(cyclo)alkyl-carbamoyl-methoxy-phenyl]-(2-chloro)-5′-N-ethylcarboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A2B adenosine receptor. Bioorganic & Medicinal Chemistry 15:7, pages 2514-2527.
Crossref
Crossref
T.D. Ashton & Peter J. Scammells. (2006) An expedient synthesis of N6-substituted-5′-modified adenosines. Bioorganic & Medicinal Chemistry Letters 16:17, pages 4564-4566.
Crossref
Crossref
Michael P. DeNinno, Hiroko Masamune, Lois K. Chenard, Kenneth J. DiRico, Cynthia Eller, John B. Etienne, Jeanene E. Tickner, Scott P. Kennedy, Delvin R. Knight, Jimmy Kong, Joseph J. Oleynek, W. Ross Tracey & Roger J. Hill. (2006) The synthesis of highly potent, selective, and water-soluble agonists at the human adenosine A3 receptor. Bioorganic & Medicinal Chemistry Letters 16:9, pages 2525-2527.
Crossref
Crossref
M Bauser, G Delapierre, M Hauswald, T Flessner, D D'Urso, A Hermann, B Beyreuther, J De Vry, P Spreyer, E Reissmüller & H Meier. (2004) Discovery and optimization of 2-aryl oxazolo-pyrimidines as adenosine kinase inhibitors using liquid phase parallel synthesis. Bioorganic & Medicinal Chemistry Letters 14:8, pages 1997-2000.
Crossref
Crossref
Zuzana Hoferová, Michal Hofer, Milan Pospíšil, Vladimír Znojil & Kateřina Chramostová. (2003) Effects of synthetic adenosine receptor agonists on growth characteristics of G:5:113 fibrosarcoma cells In Vitro. Drug Development Research 60:4, pages 303-311.
Crossref
Crossref
Michael P. DeNinno, Hiroko Masamune, Lois K. Chenard, Kenneth J. DiRico, Cynthia Eller, John B. Etienne, Jeanene E. Tickner, Scott P. Kennedy, Delvin R. Knight, Jimmy Kong, Joseph J. Oleynek, W. Ross Tracey & Roger J. Hill. (2002)
3‘-Aminoadenosine-5‘-uronamides: Discovery of the First Highly Selective Agonist at the Human Adenosine A
3
Receptor
. Journal of Medicinal Chemistry 46:3, pages 353-355.
Crossref
Crossref